Related Experiment Video

Updated: Apr 27, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.8K

Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy

Raghavendra Gowda1, Nathan R Jones2, Shubhadeep Banerjee3

  • 1Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA ; Penn State Hershey Melanoma Center, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA ; Penn State Melanoma Therapeutics Program, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA ; The Foreman Foundation for Melanoma Research, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

Journal of Nanomedicine & Nanotechnology
|July 12, 2014
PubMed

Insights

Multi-target inhibitors (MTIs) combat complex diseases like cancer by hitting multiple pathways. Nanotechnology offers a promising solution for safe and effective delivery of these agents to tumors, enhancing efficacy and reducing side effects.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Cancer's multifactorial nature necessitates multi-target inhibitors (MTIs) over single-target agents to overcome resistance.
  • MTIs include single drug inhibitors (SDIs) affecting multiple pathways and multi-drug inhibitors (MDIs) combining agents.
  • Effective MTIs require safe delivery and tumor-specific accumulation to minimize systemic toxicity.

Purpose of the Study:

  • To review the application of nanotechnology in developing multi-target inhibitors for cancer therapy.
  • To discuss the future potential and challenges of nanoparticle-based MTIs.

Main Methods:

  • Review of current literature on multi-target inhibitors and nanotechnology in cancer therapy.
  • Discussion of drug delivery mechanisms utilizing nanotechnology for MTIs.
  • Analysis of challenges and future directions in nanoparticle-based MTI development.

Main Results:

  • Nanotechnology enables targeted delivery of MTIs, improving tumor accumulation.
  • Targeted delivery enhances therapeutic efficacy while minimizing off-target and systemic side effects.
  • Nanoparticle-based MTIs represent a promising future direction for cancer treatment.

Conclusions:

  • Nanotechnology is crucial for developing effective and safe multi-target inhibitors for cancer.
  • Overcoming challenges in nanoparticle-based MTI development is key to realizing their full therapeutic potential.
  • Future research should focus on advancing nanoparticle delivery systems for enhanced MTI efficacy.
Keywords:
Cancer therapyMulti-drug inhibitorsMulti-target inhibitorsNanoliposomesNanotechnology

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

866
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

9.8K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
156